China Clinical Trial Crunch Continues But Innovative New Drug Studies Rebound

 
• By Dexter Jie Yan

COVID-19 drug trials continue to dominate clinical study landscape two years into the pandemic despite only sporadic infections in China, biotech executives and healthcare professionals say.

clinical trial progress
H1 Newly Launched Phase I-III Clinical Trials In China Second Only To The US • Source: Alamy

More from China

More from Focus On Asia